Received Aug 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
pain at the injection site; redness at the injection site; swelling at the injection site; Muscle pain; Tiredness; Headache; Shivering; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 29-JUL-2025, the patient received the 2nd dose of Shingles vaccine. In JUL-2025, an unknown time after receiving Shingles vaccine, the patient experienced injection site pain (Verbatim: pain at the injection site), injection site erythema (Verbatim: redness at the injection site), injection site swelling (Verbatim: swelling at the injection site), muscle pain (Verbatim: Muscle pain), tiredness (Verbatim: Tiredness), headache (Verbatim: Headache) and shivering (Verbatim: Shivering). The outcome of the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache and shivering were not resolved. It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache and shivering to be related to Shingles vaccine. It was unknown if the company considered the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache and shivering to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 30-JUL-2025 This case was reported by a patient via interactive digital media. Patient got the 2nd shingles shot and experienced pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering. Also asked What can they have to feel better.